NDLI: A Multimodal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia

Content Provider	JAMA Network
Author	Lesh, Tyler A. Tanase, Costin Geib, Benjamin R. Niendam, Tara A. Yoon, Jong H. Minzenberg, Michael J. Ragland, J. Daniel Solomon, Marjorie Carter, Cameron S.
Copyright Year	2015
Abstract	Importance: Recent data suggest that treatment with antipsychotics is associated with reductions in cortical gray matter in patients with schizophrenia. These findings have led to concerns about the effect of antipsychotic treatment on brain structure and function; however, no studies to date have measured cortical function directly in individuals with schizophrenia and shown antipsychotic-related reductions of gray matter. Objective: To examine the effects of antipsychotics on brain structure and function in patients with first-episode schizophrenia, using cortical thickness measurements and administration of the AX version of the Continuous Performance Task ( AX- CPT) during event-related functional magnetic resonance imaging. Design, Setting, and Participants: This case-control cross-sectional study was conducted at the Imaging Research Center of the University of California, Davis, from November 2004 through July 2012. Participants were recruited on admission into the Early Diagnosis and Preventive Treatment Clinic, an outpatient clinic specializing in first-episode psychosis. Patients with first-episode schizophrenia who received atypical antipsychotics (medicated patient group) (n = 23) and those who received no antipsychotics (unmedicated patient group) (n = 22) and healthy control participants (n = 37) underwent functional magnetic resonance imaging using a 1.5- T scanner. Main Outcomes and Measures: Behavioral performance was measured by trial accuracy, reaction time, and d′-context score. Voxelwise statistical parametric maps tested differences in functional activity during the AX- CPT, and vertexwise maps of cortical thickness tested differences in cortical thickness across the whole brain. Results: Significant cortical thinning was identified in the medicated patient group relative to the control group in prefrontal (mean reduction [ MR], 0.27 mm; P < .001), temporal ( MR, 0.34 mm; P = .02), parietal ( MR, 0.21 mm; P = .001), and occipital ( MR, 0.24 mm; P = .001) cortices. The unmedicated patient group showed no significant cortical thickness differences from the control group after clusterwise correction. The medicated patient group showed thinner cortex compared with the unmedicated patient group in the dorsolateral prefrontal cortex ( DLPFC) ( MR, 0.26 mm; P = .001) and temporal cortex ( MR, 0.33 mm; P = .047). During the AX- CPT, both patient groups showed reduced DLPFC activity compared with the control group ( P = .02 compared with the medicated group and: P < .001 compared with the unmedicated group). However, the medicated patient group demonstrated higher DLPFC activation ( P = .02) and better behavioral performance ( P = .02) than the unmedicated patient group. Conclusions and Relevance: These findings highlight the complex relationship between antipsychotic treatment and the structural, functional, and behavioral deficits repeatedly identified in schizophrenia. Although short-term treatment with antipsychotics was associated with prefrontal cortical thinning, treatment was also associated with better cognitive control and increased prefrontal functional activity. This study adds important context to the growing literature on the effects of antipsychotics on the brain and suggests caution in interpreting neuroanatomical changes as being related to a potentially adverse effect on brain function.
Ending Page	234
Starting Page	226
Page Count	9
File Format	PDF HTM / HTML
ISSN	2168622X
DOI	10.1001/jamapsychiatry.2014.2178
Issue Number	3
Journal	JAMA Psychiatry
Volume Number	72
Language	English
Publisher	American Medical Association
Publisher Date	2015-03-01
Access Restriction	Open
Subject Keyword	antipsychotic agents prefrontal cortex schizophrenia behavior brain brain imaging gray matter atypical antipsychotic functional magnetic resonance imaging
Content Type	Text
Resource Type	Article
Subject	Psychiatry and Mental Health

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Short-term Effects of Antipsychotic Treatment on Cerebral Function in Drug-Naive First-Episode Schizophrenia Revealed by “Resting State” Functional Magnetic Resonance Imaging

Reduced Dorsal and Orbital Prefrontal Gray Matter Volumes in Schizophrenia

Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis

Sensory Information Processing in Neuroleptic-Naive First-Episode Schizophrenic Patients: A Functional Magnetic Resonance Imaging Study

Brain Volume Changes in First-Episode Schizophrenia: A 1-Year Follow-up Study

Reduced Gray Matter Volume in Schizophrenia

A Multimodal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia

Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics

A Multimodal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia

Similar Documents

Short-term Effects of Antipsychotic Treatment on Cerebral Function in Drug-Naive First-Episode Schizophrenia Revealed by “Resting State” Functional Magnetic Resonance Imaging

Reduced Dorsal and Orbital Prefrontal Gray Matter Volumes in Schizophrenia

Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis

Sensory Information Processing in Neuroleptic-Naive First-Episode Schizophrenic Patients: A Functional Magnetic Resonance Imaging Study

Brain Volume Changes in First-Episode Schizophrenia: A 1-Year Follow-up Study

Reduced Gray Matter Volume in Schizophrenia

A Multimodal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia

Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics

A Multimodal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia